Your browser doesn't support javascript.
loading
Quantifying drug-induced structural toxicity in hepatocytes and cardiomyocytes derived from hiPSCs using a deep learning method.
Maddah, Mahnaz; Mandegar, Mohammad A; Dame, Keri; Grafton, Francis; Loewke, Kevin; Ribeiro, Alexandre J S.
Afiliação
  • Maddah M; Dana Solutions, Palo Alto, CA, USA.
  • Mandegar MA; Tenaya Therapeutics, South San Francisco, CA, USA.
  • Dame K; Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Grafton F; Tenaya Therapeutics, South San Francisco, CA, USA.
  • Loewke K; Dana Solutions, Palo Alto, CA, USA.
  • Ribeiro AJS; Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: alexandre.ribeiro@fda.hhs.gov.
J Pharmacol Toxicol Methods ; 105: 106895, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32629158
ABSTRACT
Cardiac and hepatic toxicity result from induced disruption of the functioning of cardiomyocytes and hepatocytes, respectively, which is tightly related to the organization of their subcellular structures. Cellular structure can be analyzed from microscopy imaging data. However, subtle or complex structural changes that are not easily perceived may be missed by conventional image-analysis techniques. Here we report the evaluation of PhenoTox, an image-based deep-learning method of quantifying drug-induced structural changes using human hepatocytes and cardiomyocytes derived from human induced pluripotent stem cells. We assessed the ability of the deep learning method to detect variations in the organization of cellular structures from images of fixed or live cells. We also evaluated the power and sensitivity of the method for detecting toxic effects of drugs by conducting a set of experiments using known toxicants and other methods of screening for cytotoxic effects. Moreover, we used PhenoTox to characterize the effects of tamoxifen and doxorubicin-which cause liver toxicity-on hepatocytes. PhenoTox revealed differences related to loss of cytochrome P450 3A4 activity, for which it showed greater sensitivity than a caspase 3/7 assay. Finally, PhenoTox detected structural toxicity in cardiomyocytes, which was correlated with contractility defects induced by doxorubicin, erlotinib, and sorafenib. Taken together, the results demonstrated that PhenoTox can capture the subtle morphological changes that are early signs of toxicity in both hepatocytes and cardiomyocytes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatócitos / Miócitos Cardíacos / Avaliação Pré-Clínica de Medicamentos / Células-Tronco Pluripotentes Induzidas / Cardiotoxicidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatócitos / Miócitos Cardíacos / Avaliação Pré-Clínica de Medicamentos / Células-Tronco Pluripotentes Induzidas / Cardiotoxicidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article